JBIO Jade Biosciences, Inc.
Healthcare$22.21-5.33%ClosedMarket Cap: $724.6M
As of 2026-05-25
Insider Statistics (Q1 2026)
Acquisitions
8
Dispositions
0
Buy/Sell Ratio
0.00
Net Shares
+1,301,563
Shares Acquired
1,301,563
Shares Disposed
0
Total Bought ($)
$0.00
Total Sold ($)
$0.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Fri Feb 13 | King Andrew James | officer: See Remarks | Sell | 247,500 | $14.81 | 247,500 |
| Fri Feb 13 | King Andrew James | officer: See Remarks | Sell | 41,250 | $0.00 | 386,113 |
| Fri Feb 13 | Frohlich Tom | director, officer: Chief Executive Officer | Sell | 472,500 | $14.81 | 472,500 |
| Fri Feb 13 | Frohlich Tom | director, officer: Chief Executive Officer | Sell | 78,750 | $0.00 | 86,331 |
| Fri Feb 13 | Dahms Bradford D. | officer: Chief Financial Officer | Sell | 226,875 | $14.81 | 226,875 |
| Fri Feb 13 | Dahms Bradford D. | officer: Chief Financial Officer | Sell | 37,813 | $0.00 | 37,813 |
| Fri Feb 13 | Balta Elizabeth | officer: See Remarks | Sell | 168,750 | $14.81 | 168,750 |
| Fri Feb 13 | Balta Elizabeth | officer: See Remarks | Sell | 28,125 | $0.00 | 28,125 |
| Wed Oct 08 | Fairmount Funds Management LLC | director, 10 percent owner: | Sell | 1,333,126 | $9.14 | 1,897,677 |
| Wed Oct 08 | Fairmount Funds Management LLC | director, 10 percent owner: | Sell | 855,047 | $0.00 | 855,047 |